Clinical trial
Evaluation of Vaccination Against Influenza (Seasonal and H1N1) in Patients Presenting Systemic or Autoimmune Diseases Treated or Not With Steroids, and/or Immunosuppressant, and/or Biotherapy: an Open, Prospective Trial (MAIVAX)
NCT01065285 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Vaccination Against Influenza (Seasonal and H1N1) in Patients Presenting Systemic or Autoimmune Diseases Treated or Not With Steroids, and/or Immunosuppressant, and/or Biotherapy: an Open, Prospective Trial (MAIVAX)
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- February 29, 2012
- Enrollment
- 234 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.